Antibiotic (ATB) therapy and outcome from nivolumab (N) in metastatic renal cell carcinoma (mRCC) patients (pts): Results of the GETUG-AFU 26 NIVOREN multicentric phase II study

Affiliation auteurs!!!! Error affiliation !!!!
TitreAntibiotic (ATB) therapy and outcome from nivolumab (N) in metastatic renal cell carcinoma (mRCC) patients (pts): Results of the GETUG-AFU 26 NIVOREN multicentric phase II study
Type de publicationJournal Article
Year of Publication2021
AuteursDerosa L., C. Silva ACosta, Dalban C., Colomba E., Negrier S., Chevreau C.M, Gravis G., Oudard S.M, Laguerre B., Barthelemy P., Borchiellini D., Gross-Goupil M., Geoffrois L., Rolland F., Thiery-Vuillemin A., Joly F., Ladoire S., Tantot F., Escudier B., Albiges L.
JournalANNALS OF ONCOLOGY
Volume32
PaginationS681
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1016/j.annonc.2021.08.053